Cargando…
B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3
The molecular interactions between B-cell precursor acute lymphoblastic leukemia (pre-B ALL) cells and stromal cells in the bone marrow that provide microenvironmentally-mediated protection against therapeutic drugs are not well-defined. Galectin-3 (Lgals3) is a multifunctional galactose-binding lec...
Autores principales: | Fei, Fei, Joo, Eun Ji, Tarighat, Somayeh S., Schiffer, Isabelle, Paz, Helicia, Fabbri, Muller, Abdel-Azim, Hisham, Groffen, John, Heisterkamp, Nora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484463/ https://www.ncbi.nlm.nih.gov/pubmed/25869099 |
Ejemplares similares
-
Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
por: Paz, Helicia, et al.
Publicado: (2018) -
Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Fei, Fei, et al.
Publicado: (2022) -
Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia
por: George, Aswathi A., et al.
Publicado: (2015) -
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia
por: Tarighat, Somayeh S., et al.
Publicado: (2021) -
Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells
por: Fei, Fei, et al.
Publicado: (2014)